This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Neurocycle Therapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: YuXi Ning: Innovator in GABAA Positive Allosteric Modulators
Introduction
YuXi Ning is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of GABAA positive allosteric modulators. His innovative work has the potential to impact therapeutic approaches for various neurological conditions.
Latest Patents
YuXi Ning holds a patent for GABAA positive allosteric modulator compounds, methods of making, and uses thereof. The patent describes polymorphs comprising 2',6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b][1,2,4]tri-azin-7-yl]biphenyl-2-carbonitrile (TPA023B) or salts thereof. Notably, the patent includes a crystalline polymorphic salt or co-crystal of TPA023B with phosphoric acid, as well as with sulfuric acid. Additionally, it outlines methods of making and utilizing these compounds.
Career Highlights
YuXi Ning is currently associated with Neurocycle Therapeutics, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the pharmaceutical industry.
Collaborations
YuXi Ning collaborates with Jed Hubbs, contributing to the advancement of their shared research goals. Their partnership exemplifies the importance of teamwork in the pursuit of scientific breakthroughs.
Conclusion
YuXi Ning's contributions to the field of GABAA positive allosteric modulators highlight his role as an influential inventor. His innovative patent work and collaboration with colleagues position him as a key figure in the ongoing development of therapeutic solutions.